Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Retatrutide is an investigational once-weekly triple agonist that targets GLP-1, GIP, and glucagon receptors
Patients should be aware that the full safety profile of retatrutide is still being established, and it is not currently available through NHS prescribing pathways
After reconstituting, calculate your new concentration: total mg of powder divided by total mL of water added
Retrieved from Wharton, S., Davies, M., Dicker, D., et al
US$ 24.57
)
US$ 20.99
US$ 28.27
/assets/images/provider/photos/2775905.jpeg)
US$ 26.33
